Loughborough University
Leicestershire, UK
LE11 3TU
+44 (0)1509 263171
Loughborough University

Loughborough University Institutional Repository

Please use this identifier to cite or link to this item: https://dspace.lboro.ac.uk/2134/36598

Title: Development of L-Asparaginase biobetters: Current research status and review of the desirable quality profiles
Authors: Brumano, Larissa P.
da Silva, Francisco Vitor S.
Costa-Silva, Tales Alexandre
Apolinario, Alexsandra C.
Santos, Joao Henrique P.
Kleingesinds, Eduardo K.
Monteiro, Gisele
Rangel-Yagui, Carlota D.
Benyahia, Brahim
Junior, Adalberto P.
Keywords: L-asparaginase
Quality-by-design
Biobetters
Protein engineering
PEGylation
Nanobiotechnology
Acute lymphoblastic leukemia
Site-directed mutagenesis
Issue Date: 2019
Publisher: © The Authors. Publsihed by Frontiers
Citation: BRUMANO, L.P. ... et al., 2019. Development of L-Asparaginase biobetters: Current research status and review of the desirable quality profiles. Frontiers in Bioengineering and Biotechnology, 6 :212.
Abstract: L-Asparaginase (ASNase) is a vital component of the first line treatment of acute lymphoblastic leukemia (ALL), an aggressive type of blood cancer expected to afflict over 53,000 people worldwide by 2020. More recently, ASNase has also been shown to have potential for preventing metastasis from solid tumors. The ASNase treatment is, however, characterized by a plethora of potential side effects, ranging from immune reactions to severe toxicity. Consequently, in accordance with Quality-by-Design (QbD) principles, ingenious new products tailored to minimize adverse reactions while increasing patient survival have been devised. In the following pages, the reader is invited for a brief discussion on the most recent developments in this field. Firstly, the review presents an outline of the recent improvements on the manufacturing and formulation processes, which can severely influence important aspects of the product quality profile, such as contamination, aggregation and enzymatic activity. Following, the most recent advances in protein engineering applied to the development of biobetter ASNases (i.e., with reduced glutaminase activity, proteolysis resistant and less immunogenic) using techniques such as site-directed mutagenesis, molecular dynamics, PEGylation, PASylation and bioconjugation are discussed. Afterwards, the attention is shifted toward nanomedicine including technologies such as encapsulation and immobilization, which aim at improving ASNase pharmacokinetics. Besides discussing the results of the most innovative and representative academic research, the review provides an overview of the products already available on the market or in the latest stages of development. With this, the review is intended to provide a solid background for the current product development and underpin the discussions on the target quality profile of future ASNase-based pharmaceuticals.
Description: This is an Open Access Article. It is published by Frontiers under the Creative Commons Attribution 4.0 Unported Licence (CC BY). Full details of this licence are available at: http://creativecommons.org/licenses/by/4.0/
Sponsor: We would like to thank the São Paulo Research Foundation (FAPESP) [Award Number 2013/08617-7, 2014/10456-4, 2015/07749-2, 2016-22065-5, 2017/21819-9, and 2018/03734-9], the Brazilian National Council for Scientific and Technological Development (CNPq) [Award Number 303334/2014-2], the National Postdoctoral Program (PNPD/Capes-FCFUSP) [Award Number 1781837], the Coordination for the Improvement of Higher Education Personnel (CAPES) [Financial Number 001] and the Portuguese Foundation for Science and Technology (FCT) for the doctoral grant SFRH/BD/102915/2014 for the financial support.
Version: Published
DOI: 10.3389/fbioe.2018.00212
URI: https://dspace.lboro.ac.uk/2134/36598
Publisher Link: https://doi.org/10.3389/fbioe.2018.00212
ISSN: 2296-4185
Appears in Collections:Published Articles (Chemical Engineering)

Files associated with this item:

File Description SizeFormat
Benyahia_fbioe-06-00212.pdfPublished version1.82 MBAdobe PDFView/Open

 

SFX Query

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.